Will Marijuana Be Rescheduled in 2026? Predictions & Analysis

Answer: Yes, substantive movement on rescheduling marijuana from Schedule I to Schedule III is highly likely in 2026. Following President Trump’s expedited order and the HHS recommendation, the DEA is expected to advance the rulemaking process, although final implementation may face procedural delays and litigation. Concurrently, the consumable hemp market will likely be redefined rather than banned.

Key Takeaways:

Rescheduling Momentum: Executive orders and HHS backing are fast-tracking the shift to Schedule III.
Hemp Survival: Consumable hemp will likely survive but shift towards low-THC and CBD-dominant products.
Tax Relief: Rescheduling would eliminate Section 280E, offering massive tax relief to cannabis businesses.
Legal Battles: Expect Supreme Court rulings on gun rights for users and lawsuits challenging DEA processes.

Marijuana rescheduling refers to the federal process of moving cannabis from the highly restrictive Schedule I category to Schedule III, a change that would acknowledge its medical value and significantly reduce regulatory burdens for researchers and businesses. As we enter 2026, the cannabis industry is poised for one of its most consequential years, driven by executive actions and evolving legal landscapes.

2026: The Year for Real Movement in Rescheduling?

President Trump’s December 18 executive order directing Attorney General Pam Bondi to expedite the rescheduling of marijuana has injected urgent momentum into a decades-long struggle. Unlike past efforts, this initiative stands on firmer ground.

The Department of Health and Human Services (HHS) has already recommended rescheduling, a critical prerequisite that allows the Drug Enforcement Administration (DEA) to proceed. The DEA began its notice-and-comment rulemaking phase with a notice of proposed rulemaking published in May 2024.

However, the path isn’t entirely clear. The agency must review a record-breaking 43,000 public comments. While the administration’s intent is clear, significant legal steps remain. We anticipate:

Resolution of procedural challenges.
Potential administrative hearings.
Litigation from opposition groups, some of which have already been filed.

The Fate of Consumable Hemp: Redefined, Not Banned

The consumable hemp industry faced an existential threat in late 2025, but the executive order provided a crucial lifeline. By instructing the White House to work with Congress on redefining legal hemp, the administration signaled a shift away from a total ban.

We predict the landscape will evolve as follows:

Product Category	Predicted Status in 2026	Market Outlook
Low-THC / CBD Products	Likely Legal & Regulated	Will dominate the compliant hemp market.
Intoxicating Hemp (High THC)	Restricted / Rescheduled	Likely moved to state-legal marijuana programs.
Synthetic Cannabinoids	Highly Restricted	Face potential bans or strict safety hurdles.

State Markets and the Impact of Section 280E

State-legal cannabis markets have largely struggled with contraction and consolidation due to heavy tax burdens. The most immediate financial impact of rescheduling would be the removal of marijuana from Section 280E of the tax code.

This change would finally allow cannabis businesses to deduct standard operating expenses like rent and payroll, drastically improving cash flow and investment potential. While the full economic boom may take time, 2026 will serve as a critical planning period for operators preparing for a Schedule III reality.

Supreme Court Predictions: Guns and Cannabis

Beyond rescheduling, the judiciary will play a pivotal role. We predict the Supreme Court may find the federal ban on gun ownership for marijuana users unconstitutional.

Given the Court’s recent expansive rulings on the Second Amendment, it is increasingly likely they will conclude that marijuana users cannot be categorically prohibited from owning firearms. Such a ruling would not only impact gun rights but could also signal a broader judicial skepticism towards federal marijuana prohibitions.

Author
Recent Posts

Sophia Bennett

Author at Ecigator

Sophia Bennett has dedicated her career to monitoring and analyzing the regulatory landscape and news within the vape industry. With a keen eye for the evolving policies that shape this dynamic market, Sophia brings a critical perspective to her commentary and reports.

Latest posts by Sophia Bennett (see all)